Trademark search
The 50 closest matches for of record for one attorney.
| Mark | Status | Office | Owner | Classes | Filed |
|---|---|---|---|---|---|
| G12C | examining | USPTO | Eli Lilly and Company | 5 | 2026-08-10 |
| G 12 C | examining | USPTO | Eli Lilly and Company | 5 | 2026-08-10 |
| YIELM | pending publication | USPTO | Eli Lilly and Company | 5 | 2026-08-05 |
| YEZRETA | pending publication | USPTO | Eli Lilly and Company | 5 | 2026-08-05 |
| YEZZRETA | pending publication | USPTO | Eli Lilly and Company | 5 | 2026-08-05 |
| YEZRET | pending publication | USPTO | Eli Lilly and Company | 5 | 2026-08-05 |
| HIRETA | examining | USPTO | Eli Lilly and Company | 5 | 2026-08-04 |
| VYMRETA | examining | USPTO | Eli Lilly and Company | 5 | 2026-08-04 |
| RETAHNOVA | examining | USPTO | Eli Lilly and Company | 5 | 2026-08-04 |
| VYMMRETA | examining | USPTO | Eli Lilly and Company | 5 | 2026-08-04 |
| RETAHVERA | examining | USPTO | Eli Lilly and Company | 5 | 2026-08-04 |
| VERAHRETA | examining | USPTO | Eli Lilly and Company | 5 | 2026-08-04 |
| VYNNRETA | examining | USPTO | Eli Lilly and Company | 5 | 2026-08-04 |
| VYNRETA | examining | USPTO | Eli Lilly and Company | 5 | 2026-08-04 |
| NEXVOUND | pending publication | USPTO | Eli Lilly and Company | 5 | 2026-07-20 |
| BRAKLAYMA | allowed | USPTO | Eli Lilly and Company | 5 | 2026-07-15 |
| IPGUAZU | pending publication | USPTO | Eli Lilly and Company | 5 | 2026-07-15 |
| SOHENJI | pending publication | USPTO | Eli Lilly and Company | 5 | 2026-07-15 |
| ZAYLAWAI | pending opposition | USPTO | Eli Lilly and Company | 5 | 2026-07-15 |
| ZAYLAWEI | allowed | USPTO | Eli Lilly and Company | 5 | 2026-07-15 |
| YUZEVNI | pending publication | USPTO | Eli Lilly and Company | 5 | 2026-07-08 |
| ZAVQY | examining | USPTO | Eli Lilly and Company | 5 | 2026-07-02 |
| BRYLZ | pending publication | USPTO | Eli Lilly and Company | 5 | 2026-07-02 |
| JEYCIO | pending publication | USPTO | Eli Lilly and Company | 5 | 2026-07-02 |
| ITEGVO | pending publication | USPTO | Eli Lilly and Company | 5 | 2026-07-02 |
| JIQAT | pending publication | USPTO | Eli Lilly and Company | 5 | 2026-06-30 |
| GRAKANYO | allowed | USPTO | Eli Lilly and Company | 5 | 2026-06-26 |
| BRYJURNI | allowed | USPTO | Eli Lilly and Company | 5 | 2026-06-26 |
| BREHELD | allowed | USPTO | Eli Lilly and Company | 5 | 2026-06-26 |
| RAKLAYMA | allowed | USPTO | Eli Lilly and Company | 5 | 2026-06-26 |
| EVERJURNI | allowed | USPTO | Eli Lilly and Company | 5 | 2026-06-26 |
| KRUZMIO | allowed | USPTO | Eli Lilly and Company | 5 | 2026-06-26 |
| IPZYKRA | pending publication | USPTO | Eli Lilly and Company | 5 | 2026-06-26 |
| BRYWAYV | pending publication | USPTO | Eli Lilly and Company | 5 | 2026-06-26 |
| AKROPLYZ | allowed | USPTO | Eli Lilly and Company | 5 | 2026-06-26 |
| JOSBRI | pending publication | USPTO | Eli Lilly and Company | 5 | 2026-06-26 |
| MUVBRAVLY | allowed | USPTO | Eli Lilly and Company | 5 | 2026-06-25 |
| [Design Mark] | examining | USPTO | Eli Lilly and Company | 5, 44 | 2026-06-25 |
| [Design Mark] | examining | USPTO | Eli Lilly and Company | 5, 44 | 2026-06-25 |
| G12C | examining | USPTO | Eli Lilly and Company | 44 | 2026-06-25 |
| G12C | examining | USPTO | Eli Lilly and Company | 44 | 2026-06-25 |
| BRAYJURNI | allowed | USPTO | Eli Lilly and Company | 5 | 2026-06-25 |
| BRAYVDURI | allowed | USPTO | Eli Lilly and Company | 5 | 2026-06-25 |
| YOZIMIDI | allowed | USPTO | Eli Lilly and Company | 5 | 2026-06-25 |
| GRANKANYO | allowed | USPTO | Eli Lilly and Company | 5 | 2026-06-25 |
| ONE AND DONE | examining | USPTO | Adverum Biotechnologies, Inc. | 44 | 2026-06-16 |
| FOUNDAYO | pending publication | USPTO | Eli Lilly and Company | 44 | 2026-06-15 |
| ZEPBOUND | pending publication | USPTO | Eli Lilly and Company | 44 | 2026-06-09 |
| ZEPBOUND | pending publication | USPTO | Eli Lilly and Company | 44 | 2026-06-09 |
| NEXMAGNY | allowed | USPTO | Eli Lilly and Company | 5 | 2026-05-20 |